<!DOCTYPE html SYSTEM "about:legacy-compat">
<html lang="en-US" class="no-js">
  <head>
    <meta charset="utf-8"/>
    <title>Chapter 80 Community-Based Substance Use Disorder Services | Library of Maryland Regulations</title>
    <link rel="shortcut icon" href="/us/md/exec/_document/v2/images/favicons/favicon.ico"/>
    <!--Meta-->
    <meta http-equiv="X-UA-Compatible" content="IE=EDGE"/>
    <meta name="viewport" content="width=device-width, initial-scale=1"/>
    <meta name="format-detection" content="telephone=no"/>
    <meta name="HandheldFriendly" content="true"/>
    <meta itemprop="full-html" content="/us/md/exec/comar/10.09.80/index.full.html" data-document="href"/>
    <meta itemprop="toc-json" content="/us/md/exec/comar/10.09.80/index.json" data-document="href"/>
    <meta itemprop="parent-doc-url" content="/us/md/exec/comar" data-document="href"/>
    <meta itemprop="order" content="|10|09|80|"/>
    <meta itemprop="doc-type" content="container" data-document=""/>
    <meta itemprop="doc-num" content="80"/>
    <meta itemprop="ref-doc" content="Code of Maryland Regulations" data-document=""/>
    <meta itemprop="ref-path" content="10|09|80" data-document=""/>
    <!--OpenGraph-->
    <meta property="og:url" content="http://regs.maryland.gov//us/md/exec/comar/10.09.80"/>
    <meta property="og:type" content="article"/>
    <meta property="og:title" content="Chapter 80 Community-Based Substance Use Disorder Services | Library of Maryland Regulations"/>
    <meta property="og:image" content="http://regs.maryland.gov//us/md/exec/_document/v2/images/og/og_image.png"/>
    <!--Progressive Web App-->
    <link rel="manifest" href="/manifest.json"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="apple-mobile-web-app-status-bar-style" content="#0078EF"/>
    <meta name="apple-mobile-web-app-title" content="Library of Maryland Regulations"/>
    <meta name="theme-color" content="#0078EF"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="mobile-web-app-capable" content="yes"/>
    <!--PWA icons-->
    <link rel="apple-touch-icon" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="60x60" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-60x60-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="76x76" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-76x76-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="152x152" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-152x152-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-180x180-precomposed.png"/>
    <link rel="mask-icon" href="/us/md/exec/_document/v2/images/favicons/safari-pinned-tab.svg" color="#0078EF"/>
    <link rel="icon" type="image/png" sizes="16x16" href="/us/md/exec/_document/v2/images/favicons/favicon-16x16.png"/>
    <link rel="icon" type="image/png" sizes="32x32" href="/us/md/exec/_document/v2/images/favicons/favicon-32x32.png"/>
    <link rel="icon" type="image/png" sizes="48x48" href="/us/md/exec/_document/v2/images/favicons/favicon-48x48.png"/>
    <!--Fonts-->
    <link href="/us/md/exec/_document/v2/biticons/biticons.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/public-sans/public-sans.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/merriweather/merriweather.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/roboto-mono/roboto-mono.css" type="text/css" rel="stylesheet" data-document=""/>
    <!--Document CSS-->
    <link href="/us/md/exec/_document/v2/styles/responsive.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/main.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/print.min.css" type="text/css" rel="stylesheet" media="print" data-document=""/>
    <link href="/_reader/styles/main.min.css" type="text/css" rel="stylesheet"/>
    <script src="/_reader/js/main.js" data-document=""> </script>
    <!--Links to resources that need to be prefetched-->
    <link rel="prefetch" href="/us/md/exec/comar/10.09.80/index.full.html" as="fetch"/>
    <link rel="prefetch" href="/index.json" as="fetch"/>
    <link rel="prefetch" href="/us/md/exec/comar/10.09.80/index.json" as="fetch"/>
  </head>
  <body>
    <div role="region" id="announcer" aria-live="polite" class="sr-only" aria-atomic="true" aria-label="Live messages">
      <p id="message"> </p>
    </div>
    <nav class="visually-hidden">
      <a href="#area__content" class="skip-link">Skip to main content</a>
    </nav>
    <div id="grid" class="ns__document__maryland-dsd">
      <header id="section__header" class="ns__document__maryland-dsd">
        <div id="section__header__inner" class="ns__document__maryland-dsd">
          <div id="area__logo" class="ns__document__maryland-dsd">
            <a href="/" class="logo" aria-label="Logo - Return to library home page">
              <img src="/us/md/exec/_document/v2/images/logo/logo.png" srcset="/us/md/exec/_document/v2/images/logo/logo.png 1x, /us/md/exec/_document/v2/images/logo/logo@2x.png 2x, /us/md/exec/_document/v2/images/logo/logo@3x.png 3x" alt="Library of Maryland Regulations logo"/>
            </a>
          </div>
          <div id="area__main_title" class="ns__document__maryland-dsd">
            <div class="h__library-logotype"><span class="line1">Library of</span> <span class="line2">Maryland Regulations</span></div>
          </div>
        </div>
      </header>
      <div id="section__content" class="ns__document__maryland-dsd">
        <div id="section__content__inner" class="ns__document__maryland-dsd">
          <section id="area__breadcrumbs" class="ns__document__maryland-dsd" role="region" aria-label="Breadcrumbs">
            <input type="checkbox" id="menu-trigger" class="menu-trigger" aria-label="Mobile menu toggler"/>
            <label for="menu-trigger">
              <span class="visually-hidden">Toggle mobile menu</span>
            </label>
            <nav role="navigation" aria-label="Breadcrumb navigation">
              <div class="h__ui">Navigation</div>
              <ul class="ancestors">
                <li data-search-path="library" data-search-heading="All Documents" class="no-indent">
                  <a href="/" title="Library of Maryland Regulations">Library of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations" data-search-heading="" data-search-default="true" class="li__book-open">
                  <a href="/us/md/exec/comar" title="Code of Maryland Regulations">Code of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10" data-search-heading="">
                  <a href="/us/md/exec/comar/10" title="Title 10 MARYLAND DEPARTMENT OF HEALTH">Title 10 MARYLAND DEPARTMENT OF HEALTH</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10|09" data-search-heading="">
                  <a href="/us/md/exec/comar/10.09" title="Subtitle 09 MEDICAL CARE PROGRAMS">Subtitle 09 MEDICAL CARE PROGRAMS</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10|09|80" data-search-heading="">
                  <span title="Chapter 80 Community-Based Substance Use Disorder Services">Chapter 80 Community-Based Substance Use Disorder Services</span>
                </li>
              </ul>
            </nav>
          </section>
          <main id="area__content" class="ns__document__maryland-dsd">
            <div class="h__document-title">Code of Maryland Regulations</div>
            <article class="content" role="document" data-ref-path="10|09|80">
              <div class="tuf-authenticate">
                <h1 class="h__toc" id="/us/md/exec/comar/10.09.80">Chapter 80 Community-Based Substance Use Disorder Services</h1>
                <section class="line-group annotations">
                  <h2>Administrative History</h2>
                  <p>Effective date:</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.80.01" title=".01 Definitions.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.80.09" title=".09 Recovery and Reimbursement.">.09</a> adopted as an emergency provision effective January 1, 2010 (37:6 Md. R. 474); adopted permanently effective May 31, 2010 (37:11 Md. R. 765)</p>
                  <p>——————</p>
                  <p>Chapter revised effective December 22, 2014 (41:25 Md. R. 1480)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.80.01#B" title="">Regulation .01B</a> amended effective October 26, 2015 (42:21 Md. R. 1302); April 10, 2017 (44:7 Md. R. 356); November 14, 2022 (49:23 Md. R. 996); May 15, 2023 (50:9 Md. R. 379); August 5, 2024 (51:15 Md. R. 708)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.80.02" title=".02 License Requirements.">Regulation .02</a> amended effective October 26, 2015 (42:21 Md. R. 1302); September 25, 2017 (44:19 Md. R. 897)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.80.03" title=".03 Conditions for Provider Participation.">Regulation .03</a> amended effective October 26, 2015 (42:21 Md. R. 1302); November 14, 2022 (49:23 Md. R. 996)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.80.03#A" title="">Regulation .03A</a>, B amended effective September 25, 2017 (44:19 Md. R. 897)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.80.04" title=".04 Participant Eligibility and Referral.">Regulation .04</a> amended effective October 26, 2015 (42:21 Md. R. 1302)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.80.05" title=".05 Covered Services.">Regulation .05</a> amended effective October 26, 2015 (42:21 Md. R. 1302); April 10, 2017 (44:7 Md. R. 356); September 25, 2017 (44:19 Md. R. 897); November 14, 2022 (49:23 Md. R. 996); May 15, 2023 (50:9 Md. R. 379); August 5, 2024 (51:15 Md. R. 708)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.80.06" title=".06 Limitations.">Regulation .06</a> amended effective October 26, 2015 (42:21 Md. R. 1302); April 10, 2017 (44:7 Md. R. 356); May 15, 2023 (50:9 Md. R. 379)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.80.06#A" title="">Regulation .06A</a>, B amended effective November 14, 2022 (49:23 Md. R. 996)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.80.07#C" title="">Regulation .07C</a> amended effective October 26, 2015 (42:21 Md. R. 1302)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.80.08" title=".08 Payment Procedures.">Regulation .08</a> amended effective October 26, 2015 (42:21 Md. R. 1302); November 14, 2022 (49:23 Md. R. 996); May 15, 2023 (50:9 Md. R. 379); November 24, 2025 (52:23 Md. R. 1139)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.80.08#D" title="">Regulation .08D</a> amended effective October 24, 2016 (43:21 Md. R. 1166); April 10, 2017 (44:7 Md. R. 356); January 1, 2018 (44:26 Md. R. 1215); December 30, 2019 (46:26 Md. R. 1164)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.80.08#D" title="">Regulation .08D</a> – F amended August 5, 2024 (51:15 Md. R. 708)</p>
                  <h2>Authority</h2>
                  <p>Health-General Article, §§2-104(b), 7.5-204, 7.5-205(d), 7.5-402, 8-204(c)(1),<br/>15-103(a)(1), and 15-105(b), Annotated Code of Maryland</p>
                </section>
                <h2 id="/us/md/exec/comar/10.09.80.01" data-order="|10|09|80|.01|" data-ref-path="10|09|80|.01" class="h__section">.01 Definitions.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.80.01#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.80.01#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.01#B(1)">(1)</span> “Administrative Service Organization (ASO)” means the contractor procured by the State to provide the Department with administrative support services to operate the Maryland Public Behavioral Health System.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.01#B(2)">(2)</span> “Behavioral Health Administration (BHA)” means the administration within the Department that establishes regulatory requirements that behavioral health programs are to maintain in order to become licensed by the Department.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.01#B(3)">(3)</span> “Community-based substance use disorder program” means a program that provides services in community settings not regulated by the Health Services Cost Review Commission.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.01#B(4)">(4)</span> “DATA 2000 waived provider” means a provider who has received a waiver under the Drug Addiction and Treatment Act of 2000 which expands the clinical context of medication assisted opioid dependency treatment and permits qualified physicians, nurse practitioners, and physician assistants to dispense or prescribe certain narcotic medications that have a lower risk of abuse, like buprenorphine, in settings other than an opioid treatment program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.01#B(5)">(5)</span> “DEA” means the Drug Enforcement Administration of the U.S. Department of Justice.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.01#B(6)">(6)</span> “Department” means the Maryland Department of Health, as defined in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.36.01" title=".01 Definitions.">COMAR 10.09.36.01</a>, or its authorized agents acting on behalf of the Department.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.01#B(7)">(7)</span> “Discharge plan” means a written description of specific goals and objectives to assist the participant upon leaving treatment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.01#B(8)">(8)</span> "Documentation" means the written medical record.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.01#B(9)">(9)</span> “Individualized treatment plan” means a written plan of action that is developed and periodically updated and revised to address a participant’s specific service needs.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.01#B(10)">(10)</span> “License” means the approval issued to a program by the BHA or its designee that permits a behavioral health provider to operate in Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.01#B(11)">(11)</span> “Medical Assistance” has the meaning stated in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.24.02" title=".02 Definitions.">COMAR 10.09.24.02</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.01#B(12)">(12)</span> “Medically necessary” has the meaning stated in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.36.01" title=".01 Definitions.">COMAR 10.09.36.01</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.01#B(13)">(13)</span> “Medication management” means a visit with a physician, nurse practitioner, or physician assistant for the purpose of evaluation, prescribing, and providing medications for substance use disorder symptom reduction, withdrawal management, or medication assisted treatment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.01#B(14)">(14)</span> “Participant” means an individual who is certified as eligible for, and is receiving, Medical Assistance benefits.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.01#B(15)">(15)</span> “Peer recovery support services” means a set of nonclinical activities provided by individuals in recovery from behavioral health concerns, including substance use or addictive disorders or mental health concerns, who use their personal, lived experiences and training to support other individuals with substance use or addictive disorders.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.01#B(16)">(16)</span> “Program” has the meaning stated in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.36.01" title=".01 Definitions.">COMAR 10.09.36.01</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.01#B(17)">(17)</span> “Progress note” means an objective documentation of the participant’s progress in relation to specific treatment goals and objectives.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.01#B(18)">(18)</span> "Recovery support services" means community-based services provided to people and their families during the initiation, on-going, and post-acute stages of their recovery from substance abuse.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.01#B(19)">(19)</span> “Substance use disorder” means a maladaptive pattern of substance use leading to clinically significant impairment or distress and manifested by recurrent and significant adverse consequences related to the repeated use of substances.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.01#B(20)">(20)</span> “Substance use disorder services” means the services for which a participant’s diagnosis and treatment provider meet the criteria specified in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.08" title="Chapter 08 Maryland Medicaid Managed Care Program: Non-Capitated Covered Services">COMAR 10.67.08</a> and this chapter.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.01#B(21)">(21)</span> “Telehealth” has the meaning stated in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.49.02" title=".02 Definitions.">COMAR 10.09.49.02</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.01#B(22)">(22)</span> “Treatment plan” means a written plan that addresses the individual’s biopsychosocial needs through goals and objectives and is updated as needed according to the treatment modality.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.09.80.02" data-order="|10|09|80|.02|" data-ref-path="10|09|80|.02" class="h__section">.02 License Requirements.</h2>
                <p>To participate in the Program, a provider shall meet the license requirements stated in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.36.02" title=".02 License Requirements.">COMAR 10.09.36.02</a> and <a class="internal-link no-wrap" href="/us/md/exec/comar/10.63.01.03" title=".03 License Required.">10.63.01.03</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.09.80.03" data-order="|10|09|80|.03|" data-ref-path="10|09|80|.03" class="h__section">.03 Conditions for Provider Participation.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.80.03#A">A.</span> A provider shall be in compliance with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.36.03" title=".03 Conditions for Participation.">COMAR 10.09.36.03</a> and <a class="internal-link no-wrap" href="/us/md/exec/comar/10.63.01.05" title=".05 Requirements for Licensed Community-Based Behavioral Health Program.">10.63.01.05</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.80.03#B">B.</span> A provider of community-based substance use disorder services shall include:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.03#B(1)">(1)</span> Community-based substance use disorder providers that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.03#B(1)(a)">(a)</span> Are licensed by the Department as community-based substance use disorder providers pursuant to the requirements listed in <a class="internal-link " href="/us/md/exec/comar/10.09.80.05" title=".05 Covered Services.">Regulation .05 of this chapter</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.03#B(1)(b)">(b)</span> Maintain verification of licenses and credentials of all professionals employed by or under contract with the provider in their respective personnel files; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.03#B(1)(c)">(c)</span> Require any physician assistant employed by the provider to have a delegation agreement with the supervising physician in accordance with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.55.02" title=".02 License and Certification Requirements.">COMAR 10.09.55.02</a> and .03;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.03#B(2)">(2)</span> Federally qualified health centers in compliance with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.08" title="Chapter 08 Freestanding Clinics">COMAR 10.09.08</a>; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.03#B(3)">(3)</span> Opioid treatment programs that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.03#B(3)(a)">(a)</span> Are licensed by the Department’s Behavioral Health Administration;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.03#B(3)(b)">(b)</span> Are approved by the U.S. Drug Enforcement Administration; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.03#B(3)(c)">(c)</span> Comply with 42 CFR Part 8.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.80.03#C">C.</span> A provider of substance use disorder services shall maintain adequate documentation of each contact with a participant as part of the medical record, which, at a minimum, includes:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.03#C(1)">(1)</span> The date of service with start and end times;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.03#C(2)">(2)</span> Documents all services received by the participant;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.03#C(3)">(3)</span> The participant’s primary reason for the substance use disorder visit;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.03#C(4)">(4)</span> A description of the service provided;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.03#C(5)">(5)</span> Progress notes; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.03#C(6)">(6)</span> An official e-Signature, or a legible signature, along with the printed or typed name of the individual providing care, with the appropriate degree or title.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.80.03#D">D.</span> The providers shall make the documentation required under Regulation .05C available, as requested to carry out required activities, to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.03#D(1)">(1)</span> The Department;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.03#D(2)">(2)</span> The ASO;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.03#D(3)">(3)</span> The Core Service Agency;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.03#D(4)">(4)</span> The Local Addictions Authority;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.03#D(5)">(5)</span> The Local Behavioral Health Authority;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.03#D(6)">(6)</span> The Office of Inspector General of the Department; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.03#D(7)">(7)</span> The Office of the Attorney General Medicaid Fraud Control Unit.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.80.03#E">E.</span> A provider shall comply with all federal statutes and regulations, including the Health Insurance Portability and Accountability Act, 42 U.S.C. §1320D et seq., and implementing regulations at 45 CFR Parts 160 and 164.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.80.03#F">F.</span> If delivering services via telehealth, a provider shall comply with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.49" title="Chapter 49 Telehealth Services">COMAR 10.09.49</a> and any subregulatory guidance issued by the Department<em>.</em></p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.09.80.04" data-order="|10|09|80|.04|" data-ref-path="10|09|80|.04" class="h__section">.04 Participant Eligibility and Referral.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.80.04#A">A.</span> A participant may self-refer or be referred to substance use disorder treatment by a:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.04#A(1)">(1)</span> Provider;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.04#A(2)">(2)</span> Family member;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.04#A(3)">(3)</span> Caregiver; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.04#A(4)">(4)</span> Local health authority.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.80.04#B">B.</span> An individual is eligible for substance use disorder services if:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.04#B(1)">(1)</span> The individual meets the Department’s medical necessity criteria; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.04#B(2)">(2)</span> The service is appropriate to the specific provider type or community-based substance use disorder providers listed in <a class="internal-link " href="/us/md/exec/comar/10.09.80.05" title=".05 Covered Services.">Regulation .05 of this chapter</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.09.80.05" data-order="|10|09|80|.05|" data-ref-path="10|09|80|.05" class="h__section">.05 Covered Services.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#A">A.</span> Comprehensive substance use disorder assessment at a minimum shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#A(1)">(1)</span> Be delivered through:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#A(1)(a)">(a)</span> A BHA licensed substance use disorder treatment provider; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#A(1)(b)">(b)</span> An opioid treatment program;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#A(2)">(2)</span> Be completed before providing the community based behavioral health services listed in §<a class="internal-link " href="/us/md/exec/comar/10.09.80.05#I" title="">§BI of this regulation</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#A(3)">(3)</span> Be reviewed and approved by a licensed physician or licensed practitioner of the healing arts, within the scope of his or her practice under State law; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#A(4)">(4)</span> Include:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#A(4)(a)">(a)</span> An assessment of the following areas:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#A(4)(a)(i)">(i)</span> Drug and alcohol use; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#A(4)(a)(ii)">(ii)</span> Substance use disorder treatment history;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#A(4)(b)">(b)</span> Referrals for physical and mental health services; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#A(4)(c)">(c)</span> Recommendation for the appropriate level of substance use disorder treatment.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#B">B.</span> Peer recovery support services shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#B(1)">(1)</span> Be included as part of a written individualized treatment plan that includes specific individualized goals;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#B(2)">(2)</span> Be delivered through a BHA licensed:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#B(2)(a)">(a)</span> Outpatient substance use disorder treatment provider in compliance with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.63.03.06" title=".06 Outpatient Treatment Level 1 Program.">COMAR 10.63.03.06</a>, <a class="internal-link no-wrap" href="/us/md/exec/comar/10.63.03.03" title=".03 Intensive Outpatient Treatment Level 2.1 Program.">10.63.03.03</a> or <a class="internal-link no-wrap" href="/us/md/exec/comar/10.63.03.07" title=".07 Partial Hospitalization Treatment Level 2.5 Program.">10.63.03.07</a>; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#B(2)(b)">(b)</span> Opioid treatment program in compliance with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.63.03.19" title=".19 Opioid Treatment Service.">COMAR 10.63.03.19</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#B(3)">(3)</span> Be provided by staff who, at a minimum:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#B(3)(a)">(a)</span> Maintains active certification by BHA or its designee;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#B(3)(b)">(b)</span> Self-identifies as an individual with life experience of being diagnosed with behavioral health concerns, including substance use disorders, addictive disorders, or mental health concerns;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#B(3)(c)">(c)</span> Completes ongoing training as approved by BHA or its designee; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#B(3)(d)">(d)</span> Receives supervision by:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#B(3)(d)(i)">(i)</span> A registered peer supervisor approved by BHA or its designee; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#B(3)(d)(ii)">(ii)</span> An individual practitioner as defined in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.59.04#A(2)" title="">COMAR 10.09.59.04A(2)</a> or a certified alcohol and drug counselor who is approved to supervise by the relevant board and who must be an approved registered peer supervisor on or after September 1, 2023; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#B(4)">(4)</span> Be provided directly to the participant either in-person or via telehealth.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#C">C.</span> Level 1 group and individual substance use disorder counseling shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#C(1)">(1)</span> Comply with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.63.03.06" title=".06 Outpatient Treatment Level 1 Program.">COMAR 10.63.03.06</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#C(2)">(2)</span> Be delivered through:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#C(2)(a)">(a)</span> A BHA licensed substance use disorder treatment provider; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#C(2)(b)">(b)</span> An opioid treatment program;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#C(3)">(3)</span> Include services for participants who require less than 9 hours weekly for adults and 6 hours weekly for adolescents;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#C(4)">(4)</span> Include a written individualized treatment plan, with the participation of the participant based on the comprehensive assessment that shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#C(4)(a)">(a)</span> Be reviewed and approved by a licensed physician or licensed practitioner of the healing arts, within the scope of his or her practice under State law; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#C(4)(b)">(b)</span> Include:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#C(4)(b)(i)">(i)</span> Participant treatment plan goals;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#C(4)(b)(ii)">(ii)</span> Referrals to ancillary services, if needed; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#C(4)(b)(iii)">(iii)</span> Referral to recovery support services, if needed; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#C(5)">(5)</span> Include family members, if necessary, as long as the participant is also present in a Level 1 group counseling session.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#D">D.</span> Level 2.1 Intensive Outpatient services shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#D(1)">(1)</span> Comply with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.63.03.03" title=".03 Intensive Outpatient Treatment Level 2.1 Program.">COMAR 10.63.03.03</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#D(2)">(2)</span> Be delivered through a BHA licensed substance use disorder treatment provider only;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#D(3)">(3)</span> Include services for participants who require outpatient treatment for 9 or more hours weekly for an adult and 6 or more hours weekly for an adolescent;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#D(4)">(4)</span> Include a written individualized treatment plan, with the participation of the participant based on the comprehensive assessment that shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#D(4)(a)">(a)</span> Be reviewed and approved by a licensed physician or licensed practitioner of the healing arts, within the scope of his or her practice under State law; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#D(4)(b)">(b)</span> Include:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#D(4)(b)(i)">(i)</span> Participant treatment plan goals; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#D(4)(b)(ii)">(ii)</span> Specific interventions that reflect the amounts, frequencies and intensities appropriate to the objective of the treatment plan; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#D(5)">(5)</span> Include a discharge plan, which includes written recommendations to assist the participant with continued recovery efforts, as well as appropriate referral services.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#E">E.</span> Level 2.5 partial hospitalization services shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#E(1)">(1)</span> Comply with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.63.03.07" title=".07 Partial Hospitalization Treatment Level 2.5 Program.">COMAR 10.63.03.07</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#E(2)">(2)</span> Be delivered through a BHA licensed substance use disorder treatment provider;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#E(3)">(3)</span> Include services for participants who require a minimum of 20 hours weekly of structured outpatient treatment delivered in the following ways:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#E(3)(a)">(a)</span> Half day sessions with a minimum of 2 hours per day of services; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#E(3)(b)">(b)</span> Full day sessions with a minimum of 6 hours per day of services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#E(4)">(4)</span> Include a written individualized treatment plan, with the participation of the participant based on the comprehensive assessment that shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#E(4)(a)">(a)</span> Be reviewed and approved by a licensed physician or licensed practitioner of the healing arts, within the scope of his or her practice under State law; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#E(4)(b)">(b)</span> Include:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#E(4)(b)(i)">(i)</span> Participant treatment plan goals; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#E(4)(b)(ii)">(ii)</span> Specific interventions that reflect the amounts, frequencies and intensities appropriate to the objective of the treatment plan; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#E(5)">(5)</span> Include a discharge plan, which includes written recommendations to assist the participant with continued recovery efforts, as well as appropriate referral services.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#F">F.</span> Ambulatory withdrawal management service shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#F(1)">(1)</span> Comply with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.63.03.18" title=".18 Withdrawal Management Service.">COMAR 10.63.03.18</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#F(2)">(2)</span> Be delivered through a BHA licensed substance use disorder treatment provider;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#F(3)">(3)</span> Include the following services as medically necessary:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#F(3)(a)">(a)</span> Administration and monitoring of medication, including administration and monitoring of psychotropic medication by qualified staff, as necessary; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#F(3)(b)">(b)</span> Managing withdrawal symptoms; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#F(4)">(4)</span> Include a participant progress note added to the participant-s record after each session.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#G">G.</span> Buprenorphine and other medication assisted treatment delivered by a BHA licensed substance use disorder treatment provider that employs a practitioner who holds a DEA registration with Schedule III authority in compliance with 21 U.S.C. §823 shall include the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#G(1)">(1)</span> Services delivered by a DEA registered practitioner with Schedule III authority, including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#G(1)(a)">(a)</span> Pharmacological interventions, including the use of FDA-approved opiate agonist and partial agonist treatment medications to provide treatment, support, and recovery to opioid-addicted participants;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#G(1)(b)">(b)</span> At a minimum, medical services required to be provided by the Program that:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#G(1)(b)(i)">(i)</span> Ensure that participants receive a dose adequate to alleviate withdrawal symptoms;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#G(1)(b)(ii)">(ii)</span> Employ dose increases and behavior therapy before mandatory detoxification for participants continuing to use drugs;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#G(1)(b)(iii)">(iii)</span> Establish participant dosing based on an individual need;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#G(1)(b)(iv)">(iv)</span> Provide flexible dosage tapering and withdrawal management with dosage reductions at the participant’s request;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#G(1)(c)">(c)</span> Ordering and administering non-narcotic drugs; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#G(2)">(2)</span> Services provided by alcohol and drug counselors and other staff as appropriate, including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#G(2)(a)">(a)</span> Substance use disorder and related counseling as recommended in the individualized treatment plan; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#G(2)(b)">(b)</span> Point of care presumptive drug testing that shall be:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#G(2)(b)(i)">(i)</span> Presumptive in nature and performed at the point of care; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#G(2)(b)(ii)">(ii)</span> Capable of being read by direct optical observation only.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#H">H.</span> For dates of service before January 1, 2023, BHA licensed substance use disorder treatment providers rendering buprenorphine and other medication assisted treatment are required to comply with requirements for DATA 2000 waived providers.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#I">I.</span> Opioid maintenance therapy services delivered through the use of methadone or buprenorphine by opioid treatment programs shall comply with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.63.03.19" title=".19 Opioid Treatment Service.">10.63.03.19</a> and include:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#I(1)">(1)</span> An individualized treatment plan that shall be reviewed and approved by a licensed physician or licensed practitioner of the healing arts, within the scope of his or her practice under State law;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#I(2)">(2)</span> The following services:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#I(2)(a)">(a)</span> Pharmacological interventions, including the use of FDA-approved opiate agonist and partial agonist treatment medications to provide treatment, support, and recovery to opioid-addicted participants;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#I(2)(b)">(b)</span> Point of care presumptive drug testing;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#I(2)(c)">(c)</span> Definitive drug testing when completed by a laboratory;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#I(2)(d)">(d)</span> Substance use disorder and related counseling as recommended in the individualized treatment plan;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#I(2)(e)">(e)</span> Periodic medication management;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#I(2)(f)">(f)</span> Medical services, including, but not limited to, those required to be provided by the Program that ensure that participants receive a dose adequate to alleviate withdrawal symptoms; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#I(2)(g)">(g)</span> Ordering and administering non-narcotic drugs;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#I(3)">(3)</span> A discharge plan, which includes written recommendations to assist the participant with continued recovery efforts, as well as appropriate referral services; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#I(4)">(4)</span> Guest dosing arrangements with other opioid treatment programs, as medically necessary.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#J">J.</span> Medication assisted treatment induction service delivered by opioid treatment programs shall include the following services, as medically necessary:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#J(1)">(1)</span> Pharmacological interventions, including the use of one of the following FDA-approved opiate agonist and partial agonist treatment medications to provide treatment, support, and recovery to opioid-addicted participants:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#J(1)(a)">(a)</span> Buprenorphine; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#J(1)(b)">(b)</span> Methadone;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#J(2)">(2)</span> Medical services, including, but not limited to, those required to be provided by the Program that ensure that participants receive a dose adequate to alleviate withdrawal symptoms; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.05#J(3)">(3)</span> Ordering and administering non-narcotic drugs.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.09.80.06" data-order="|10|09|80|.06|" data-ref-path="10|09|80|.06" class="h__section">.06 Limitations.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#A">A.</span> The Program under this chapter does not cover the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#A(1)">(1)</span> Community-based substance use disorder services not specified in <a class="internal-link " href="/us/md/exec/comar/10.09.80.05" title=".05 Covered Services.">Regulation .05 of this chapter</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#A(2)">(2)</span> Community-based substance use disorder services not approved by a licensed physician or other licensed practitioner of the healing arts, within the scope of his or her practice under State law;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#A(3)">(3)</span> Services not identified by the Department as medically necessary or listed in <a class="internal-link " href="/us/md/exec/comar/10.09.80.05" title=".05 Covered Services.">Regulation .05 of this chapter</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#A(4)">(4)</span> Investigational and experimental drugs and procedures;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#A(5)">(5)</span> Substance use disorder visits solely for the purpose of:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#A(5)(a)">(a)</span> Prescribing medication;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#A(5)(b)">(b)</span> Administering medication;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#A(5)(c)">(c)</span> Drug or supply pick-up;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#A(5)(d)">(d)</span> Collecting laboratory specimens;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#A(5)(e)">(e)</span> Interpreting laboratory tests or panels; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#A(5)(f)">(f)</span> Administering injections, unless the following are documented in the participant’s medical record:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#A(5)(f)(i)">(i)</span> Medical necessity; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#A(5)(f)(ii)">(ii)</span> The participant’s inability to take appropriate oral medications;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#A(6)">(6)</span> Services that are provided in a hospital inpatient or outpatient setting or in an intermediate care facility for behavioral health;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#A(7)">(7)</span> Services beyond the provider’s scope of practice;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#A(8)">(8)</span> Services that are separately billed but included as part of another service;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#A(9)">(9)</span> Buprenorphine induction and buprenorphine maintenance therapy services that are:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#A(9)(a)">(a)</span> Delivered by a participant’s primary care provider which are the responsibility of the Managed Care Organization as specified in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.67.08" title="Chapter 08 Maryland Medicaid Managed Care Program: Non-Capitated Covered Services">COMAR 10.67.08</a>; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#A(9)(b)">(b)</span> Delivered without a primary diagnosis of substance use disorder;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#A(10)">(10)</span> Presumptive and definitive drug testing when billed by:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#A(10)(a)">(a)</span> An opioid treatment program;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#A(10)(b)">(b)</span> An intensive outpatient program; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#A(10)(c)">(c)</span> A partial hospitalization program provider; (</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#A(11)">(11)</span> Peer recovery support services that are not provided either in-person or via telehealth; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#A(12)">(12)</span> Services not authorized consistent with this chapter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#B">B.</span> Providers may not be reimbursed by the Program for:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#B(1)">(1)</span> More than one comprehensive substance use disorder assessment for a participant per provider per 12-month period unless there is a break in treatment over 30 calendar days;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#B(2)">(2)</span> More than one Level 1 group counseling session per day per participant;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#B(3)">(3)</span> More than six Level 1 individual counseling units as measured in 15 minute increments per day per participant;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#B(4)">(4)</span> More than four sessions of Level 2.1 Intensive Outpatient treatment per week;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#B(5)">(5)</span> Level 1 group or individual counseling during the same week as a Level 2.1 Intensive Outpatient treatment or Level 2.5 Partial Hospitalization service unless the participant has been discharged from or admitted to a new level of care;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#B(6)">(6)</span> Overlapping episodes of Level 2.1 Intensive Outpatient treatment and Level 2.5 Partial Hospitalization;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#B(7)">(7)</span> Level 1 group or individual counseling during the same week as Level 1 group or individual counseling offered by another provider;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#B(8)">(8)</span> Psychiatric day treatment service as described in COMAR [<a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.02.01" title=".01 Definitions.">10.09.02.01</a>] <a class="internal-link no-wrap" href="/us/md/exec/comar/10.63.03.08" title=".08 Psychiatric Day Treatment Program (PDTP).">10.63.03.08</a> or an intensive outpatient mental health service on the same day as a Level 2.1 Intensive Outpatient program or Level 2.5 Partial Hospitalization program</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#B(9)">(9)</span> Buprenorphine maintenance therapy delivered by an opioid treatment program or a BHA licensed substance use disorder treatment provider during the same week as Methadone Maintenance Therapy;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#B(10)">(10)</span> Ambulatory withdrawal management during the same week as an opioid maintenance therapy, medication assisted treatment induction, or buprenorphine maintenance service;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#B(11)">(11)</span> Medication management billed by an opioid treatment program or a BHA licensed substance use disorder treatment provider during the same days as medication assisted treatment induction;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#B(12)">(12)</span> Community-based substance use disorder services on the same day that a participant received similar services as a hospital inpatient or outpatient;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#B(13)">(13)</span> Services delivered by federally qualified health centers other than those billed using T-codes that may include the following delivered by two separate appropriately licensed providers:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#B(13)(a)">(a)</span> One T-code for mental health services per day with associated mental health procedure code; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#B(13)(b)">(b)</span> One T-code for substance use disorder services with associated H-code per day;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#B(14)">(14)</span> Services rendered but not appropriately documented to the level of service;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#B(15)">(15)</span> Services rendered by mail;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#B(16)">(16)</span> Completion of forms or reports;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#B(17)">(17)</span> Broken or missed appointments;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#B(18)">(18)</span> Travel to and from site of service; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#B(19)">(19)</span> Transportation costs.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#C">C.</span> In order to bill for an individual in Level 2.1 Intensive Outpatient treatment, the per diem session shall include a minimum of 2 hours. A maximum of 4 per diems may be billed per week.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#D">D.</span> In order to bill for an individual in Level 2.5 Partial Hospitalization, the per diem rate for a half day session shall include a minimum of 2 hours.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#E">E.</span> In order to bill for an individual in Level 2.5 Partial Hospitalization, the per diem rate for a full day session shall include a minimum of 6 hours.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#F">F.</span> The Department shall pay participating opioid treatment programs, per participant, per week provided the participant received ongoing opioid treatment medications and at least one face-to-face documented treatment service in the month for which the Program is billed.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#G">G.</span> In order for an opioid treatment program to bill for medication assisted treatment induction, the provider shall bill this service only in the first week of treatment per participant or in the first week of treatment after a break from treatment of at least 6 months.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#H">H.</span> In order for an opioid treatment program to bill for buprenorphine maintenance therapy, the provider shall bill this service per participant per week.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#I">I.</span> In order to bill for ambulatory withdrawal management, providers may bill up to 5 per diems during the detoxification episode if determined medically necessary by the Department.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#J">J.</span> Peer recovery support services may not be used to supplant the minimum billing requirements for:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#J(1)">(1)</span> Level 2.1 Intensive Outpatient treatment as described in <a class="internal-link " href="/us/md/exec/comar/10.09.80.06#C" title="">§C of this regulation</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#J(2)">(2)</span> Level 2.5 Partial Hospitalization half day session as described in <a class="internal-link " href="/us/md/exec/comar/10.09.80.06#D" title="">§D of this regulation</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#J(3)">(3)</span> Level 2.5 Partial Hospitalization full day session as described in <a class="internal-link " href="/us/md/exec/comar/10.09.80.06#E" title="">§E of this regulation</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#J(4)">(4)</span> Opioid treatment program services as described in <a class="internal-link " href="/us/md/exec/comar/10.09.80.06#F" title="">§F of this regulation</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.80.06#K">K.</span> All drug screening lab claims submitted to the ASO by providers other than opioid treatment programs shall list the applicable substance use disorder diagnosis.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.09.80.07" data-order="|10|09|80|.07|" data-ref-path="10|09|80|.07" class="h__section">.07 Authorization Requirements.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.80.07#A">A.</span> For services outlined in <a class="internal-link " href="/us/md/exec/comar/10.09.80.05" title=".05 Covered Services.">Regulation .05 of this chapter</a>, the community-based substance use disorder program shall notify the ASO and obtain authorization to provide substance use disorder services from the ASO.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.80.07#B">B.</span> The ASO agent shall authorize services that are:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.07#B(1)">(1)</span> Medically necessary; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.07#B(2)">(2)</span> Of a type, frequency, and duration that are consistent with expected results and cost-effectiveness.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.80.07#C">C.</span> No payment shall be rendered for services that have not been authorized by the Department or its designee.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.09.80.08" data-order="|10|09|80|.08|" data-ref-path="10|09|80|.08" class="h__section">.08 Payment Procedures.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#A">A.</span> General policies governing payment procedures that are applicable to all providers are set forth in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.36.04" title=".04 Payment Procedures.">COMAR 10.09.36.04</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#B">B.</span> Billing time limitations for claims submitted under this chapter are set forth in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.36.06" title=".06 Billing Time Limitations.">COMAR 10.09.36.06</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#C">C.</span> Unless the care is free to other patients, a provider shall bill the Program their usual and customary charge to the general public.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#D">D.</span> For dates of service July 1, 2023 through December 31, 2023, rates for the services outlined in this chapter shall be as follows:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#D(1)">(1)</span> For services outlined in this regulation, as delivered through a BHA licensed substance use disorder treatment provider:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#D(1)(a)">(a)</span> Comprehensive substance use disorder assessment — $198.35;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#D(1)(b)">(b)</span> Level 1 group substance use disorder counseling — $54.49 per session;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#D(1)(c)">(c)</span> Level 1 individual substance use disorder counseling — $27.93 per 15-minute increment with a maximum of six 15-minute increments per day;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#D(1)(d)">(d)</span> Level 2.1 Intensive Outpatient treatment — $174.60 per diem;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#D(1)(e)">(e)</span> Level 2.5 Partial Hospitalization half day session — $181.58 per diem;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#D(1)(f)">(f)</span> Level 2.5 Partial Hospitalization full day session — $293.31 per diem;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#D(1)(g)">(g)</span> Ambulatory Withdrawal Management —$97.78 per diem;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#D(1)(h)">(h)</span> Individual peer support services — $16.87 per 15-minute increment;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#D(1)(i)">(i)</span> Group peer support services — $4.69 per 15-minute increment;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#D(1)(j)">(j)</span> Point of care presumptive drug test read with direct optical observation only — $10.02 per test;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#D(1)(k)">(k)</span> Point of care presumptive drug test read with instrument-assisted direct optical observation — $10.02 per test;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#D(1)(l)">(l)</span> Point of care presumptive drug test read with instrumented chemistry analyzers — $49.40 per test; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#D(1)(m)">(m)</span> Periodic medication management through office-based evaluation and management visits, according to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.02.07#D" title="">COMAR 10.09.02.07D</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#D(2)">(2)</span> For services outlined in this regulation as delivered through an opioid treatment program:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#D(2)(a)">(a)</span> Comprehensive substance use disorder assessment — $198.35;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#D(2)(b)">(b)</span> Level 1 group substance use disorder counseling — $54.49 per session;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#D(2)(c)">(c)</span> Level 1 individual substance use disorder counseling — $27.93 per 15-minute increment with a maximum of six 15-minute increments per day;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#D(2)(d)">(d)</span> Opioid Maintenance Therapy — $86.27 per participant per week;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#D(2)(e)">(e)</span> Medication Assisted Treatment Induction — $279.36 per participant per week;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#D(2)(f)">(f)</span> Buprenorphine Maintenance Therapy — $76.69 per participant per week;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#D(2)(g)">(g)</span> Individual peer support services — $16.87 per 15-minute increment;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#D(2)(h)">(h)</span> Group peer support services — $4.69 per 15-minute increment; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#D(2)(i)">(i)</span> Periodic medication management through office-based evaluation and management visits, according to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.02.07#D" title="">COMAR 10.09.02.07D</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#E">E.</span> For dates of service January 1, 2024, through June 30, 2024, rates for the services outlined in this chapter shall be as follows:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#E(1)">(1)</span> For services outlined in this chapter, as delivered through a BHA licensed substance use disorder treatment provider:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#E(1)(a)">(a)</span> Comprehensive substance use disorder assessment — $214.22;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#E(1)(b)">(b)</span> Level 1 group substance use disorder counseling — $58.85 per session;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#E(1)(c)">(c)</span> Level 1 individual substance use disorder counseling — $30.16 per 15-minute increment with a maximum of six 15-minute increments per day;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#E(1)(d)">(d)</span> Level 2.1 Intensive Outpatient treatment — $188.57 per diem;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#E(1)(e)">(e)</span> Level 2.5 Partial Hospitalization half day session — $196.11 per diem;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#E(1)(f)">(f)</span> Level 2.5 Partial Hospitalization full day session — $316.77 per diem;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#E(1)(g)">(g)</span> Ambulatory Withdrawal Management —$105.60 per diem;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#E(1)(h)">(h)</span> Individual peer support services — $18.22 per 15-minute increment;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#E(1)(i)">(i)</span> Group peer support services — $5.07 per 15-minute increment;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#E(1)(j)">(j)</span> Point of care presumptive drug test read with direct optical observation only — $10.02 per test;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#E(1)(k)">(k)</span> Point of care presumptive drug test read with instrument-assisted direct optical observation — $10.02 per test;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#E(1)(l)">(l)</span> Point of care presumptive drug test read with instrumented chemistry analyzers — $49.40 per test; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#E(1)(m)">(m)</span> Periodic medication management through office-based evaluation and management visits, according to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.02.07#D" title="">COMAR 10.09.02.07D</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#E(2)">(2)</span> For services outlined in this chapter as delivered through an opioid treatment program:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#E(2)(a)">(a)</span> Comprehensive substance use disorder assessment — $214.22;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#E(2)(b)">(b)</span> Level 1 group substance use disorder counseling — $58.85 per session;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#E(2)(c)">(c)</span> Level 1 individual substance use disorder counseling — $30.16 per 15-minute increment with a maximum of six 15-minute increments per day;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#E(2)(d)">(d)</span> Opioid Maintenance Therapy — $93.17 per participant per week;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#E(2)(e)">(e)</span> Medication Assisted Treatment Induction — $301.71 per participant per week;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#E(2)(f)">(f)</span> Buprenorphine Maintenance Therapy — $82.83 per participant per week;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#E(2)(g)">(g)</span> Individual peer support services — $18.22 per 15-minute increment;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#E(2)(h)">(h)</span> Group peer support services — $5.07 per 15-minute increment; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#E(2)(i)">(i)</span> Periodic medication management through office-based evaluation and management visits, according to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.02.07#D" title="">COMAR 10.09.02.07D</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#F">F.</span> Effective July 1, 2024, rates for the services outlined in this chapter shall be as follows:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#F(1)">(1)</span> For services outlined in this chapter, as delivered through a BHA licensed substance use disorder treatment provider:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#F(1)(a)">(a)</span> Comprehensive substance use disorder assessment — $220.65;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#F(1)(b)">(b)</span> Level 1 group substance use disorder counseling — $60.62 per session;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#F(1)(c)">(c)</span> Level 1 individual substance use disorder counseling — $31.06 per 15-minute increment with a maximum of six 15-minute increments per day;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#F(1)(d)">(d)</span> Level 2.1 Intensive Outpatient treatment — $194.23 per diem;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#F(1)(e)">(e)</span> Level 2.5 Partial Hospitalization half day session — $201.99 per diem;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#F(1)(f)">(f)</span> Level 2.5 Partial Hospitalization full day session — $326.27 per diem;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#F(1)(g)">(g)</span> Ambulatory Withdrawal Management —$108.77 per diem;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#F(1)(h)">(h)</span> Individual peer support services — $18.77 per 15-minute increment;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#F(1)(i)">(i)</span> Group peer support services — $5.22 per 15-minute increment;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#F(1)(j)">(j)</span> Point of care presumptive drug test read with direct optical observation only — $10.02 per test;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#F(1)(k)">(k)</span> Point of care presumptive drug test read with instrument-assisted direct optical observation — $10.02 per test;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#F(1)(l)">(l)</span> Point of care presumptive drug test read with instrumented chemistry analyzers — $49.40 per test; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#F(1)(m)">(m)</span> Periodic medication management through office-based evaluation and management visits, according to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.02.07#D" title="">COMAR 10.09.02.07D</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#F(2)">(2)</span> For services outlined in this chapter as delivered through an opioid treatment program:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#F(2)(a)">(a)</span> Comprehensive substance use disorder assessment — $220.65;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#F(2)(b)">(b)</span> Level 1 group substance use disorder counseling — $60.62 per session;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#F(2)(c)">(c)</span> Level 1 individual substance use disorder counseling — $31.06 per 15-minute increment with a maximum of six 15-minute increments per day;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#F(2)(d)">(d)</span> Opioid Maintenance Therapy — $95.97 per participant per week;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#F(2)(e)">(e)</span> Medication Assisted Treatment Induction — $310.76 per participant per week;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#F(2)(f)">(f)</span> Buprenorphine Maintenance Therapy — $85.31 per participant per week;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#F(2)(g)">(g)</span> Individual peer support services — $18.77 per 15-minute increment;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#F(2)(h)">(h)</span> Group peer support services — $5.22 per 15-minute increment; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#F(2)(i)">(i)</span> Periodic medication management through office-based evaluation and management visits, according to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.02.07#D" title="">COMAR 10.09.02.07D</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#G">G.</span> The Program shall make no direct payment to participants.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#H">H.</span> The Department shall authorize supplemental payment on Medicare claims only if:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#H(1)">(1)</span> The provider accepts Medicare assignments;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#H(2)">(2)</span> Medicare makes direct payment to the provider;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#H(3)">(3)</span> Medicare has determined that the services are medically necessary;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#H(4)">(4)</span> The services are covered by the Program; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#H(5)">(5)</span> Initial billing is made directly to Medicare according to Medicare guidelines.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#I">I.</span> The Department shall make payment on Medicare claims subject to the following provisions:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#I(1)">(1)</span> Deductible and coinsurance shall be paid in full for services designated as mental health services by Medicare; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.08#I(2)">(2)</span> The Program shall reimburse services not covered by Medicare, but considered medically necessary by the Program, according to the limitations of this chapter.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.09.80.09" data-order="|10|09|80|.09|" data-ref-path="10|09|80|.09" class="h__section">.09 Recovery and Reimbursement.</h2>
                <p>Recovery and reimbursement shall be as set forth in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.36.07" title=".07 Recovery and Reimbursement.">COMAR 10.09.36.07</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.09.80.10" data-order="|10|09|80|.10|" data-ref-path="10|09|80|.10" class="h__section">.10 Cause for Suspension or Removal and Imposition of Sanctions.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.80.10#A">A.</span> Causes for suspension or removal and imposition of sanctions shall be as set forth in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.36.08" title=".08 Cause for Suspension or Removal and Imposition of Sanctions.">COMAR 10.09.36.08</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.09.80.10#B">B.</span> The Department shall give to the provider reasonable written notice of the Department’s intention to impose sanctions. In the notice, the Department shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.10#B(1)">(1)</span> Establish the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.10#B(1)(a)">(a)</span> Effective date of the proposed action; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.09.80.10#B(1)(b)">(b)</span> Reasons for the proposed action; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.09.80.10#B(2)">(2)</span> Advise the provider of the right to appeal.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.09.80.11" data-order="|10|09|80|.11|" data-ref-path="10|09|80|.11" class="h__section">.11 Appeal Procedures.</h2>
                <p>Appeals procedures shall be as set forth in accordance with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.36.09" title=".09 Filing Appeal.">COMAR 10.09.36.09</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.09.80.12" data-order="|10|09|80|.12|" data-ref-path="10|09|80|.12" class="h__section">.12 Interpretive Regulation.</h2>
                <p>This chapter shall be interpreted as set forth in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.36.10" title=".10 Interpretive Regulation.">COMAR 10.09.36.10</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
              </div>
            </article>
          </main>
          <nav id="area__navigation_mini" class="ns__document__maryland-dsd" aria-label="Previous and next article links">
            <section>
              <a href="/us/md/exec/comar/10.09.79" aria-label="Chapter 79 Presumptive Eligibility for Correctional Facilities">
                <div class="h__ui">Previous</div>
                <span>Chapter 79 Presumptive Eligibility for Correctional Facilities</span>
              </a>
            </section>
            <section>
              <a href="/us/md/exec/comar/10.09.81" aria-label="Chapter 81 Increased Community Services (ICS) Program">
                <div class="h__ui">Next</div>
                <span>Chapter 81 Increased Community Services (ICS) Program</span>
              </a>
            </section>
          </nav>
        </div>
      </div>
      <footer id="section__footer" class="ns__document__maryland-dsd">
        <div id="section__footer__inner" class="ns__document__maryland-dsd">
          <div id="area__footer__content" class="ns__document__maryland-dsd">
<p>This version of the laws and codes on this website is licensed under the <a href="https://creativecommons.org/licenses/by-nc-sa/4.0/">CC BY-NC-SA 4.0</a> license with copyright held by the State of Maryland.</p><p>This version of the laws and codes on this website will be dedicated to the public domain under the <a href="https://creativecommons.org/publicdomain/zero/1.0/">CC0 1.0</a> license 180 days after publication.</p>
<p>
      Please do not scrape. Instead, bulk download the CC BY-NC-SA-4.0 <a href="https://github.com/maryland-dsd/law-html">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml">XML</a> or CC0 <a href="https://github.com/maryland-dsd/law-html-cc0">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml-cc0">XML</a>.
    </p><p>Powered by the non-profit <a href="https://www.openlawlib.org/">Open Law Library</a>.</p></div>
        </div>
      </footer>
    </div>
    <!--Piwik analytics-->
    <noscript>
      <img src="/_analytics/pixel.png" style="border:0;" alt=""/>
    </noscript>
  </body>
</html>
